Learn More
STUDY OBJECTIVE To evaluate the efficacy of darbepoetin alfa 200 microg subcutaneously every 2 weeks after therapeutic substitution for epoetin alfa. DESIGN Retrospective multicenter chart review.(More)
  • 1